TERUMO CORP News

Global Pen Needles Market Report 2024-2034: Regional Analysis by Product, Needle Length, Therapy, and Distribution Channel Featuring Novo Nordisk, Terumo Corp, and Roche Diabetes Care Among Others

Yahoo FinanceMar 13 11:17 ET

Earnings Call Summary | TERUMO CORP(TRUMF.US) Q3 2024 Earnings Conference

The following is a summary of the Terumo Corporation (TRUMF) Q3 2024 Earnings Call Transcript:Financial Performance:Terumo Corporation reported highest ever revenue in Q3 2024 due to double-digit grow

moomoo AIFeb 9 00:45 ET · Conference Call

Terumo Says Revenue for Nine Months Ended December 31 Was ¥682.95B

Seeking AlphaFeb 8 10:05 ET

Terumo Corp to Undertake One-to-Two Share Split

Thermometer maker Terumo Corp. (TYO:6418) plans to split its shares and adjust its Articles of Incorporation, as decided by its board of directors on Feb. 7, 2024 to make the trading environment more

MT NewswiresFeb 8 07:53 ET

TERUMO CORP To Carry Out 2-for-1 Stock Split On March 28th, 2024

February 8th - $TERUMO CORP(TRUMF.US)$ is about to implement a 2-for-1 stock split of shares. The shares will begin trading on a split-adjusted basis from March 28th, 2024.$TERUMO CORP(TRUMF.US)$ rose

moomoo NewsFeb 7 19:40 ET

Terumo Corp 9-Mos Net Y79.90B Vs Net Y70.18B

Terumo Corp. (4543.TO) Japan Nine Months Ended December 31 GROUP 2023 2022 Revenue Y682.95 bln Y617.99 bln Operating Profit Y105.52 bln

Dow JonesFeb 7 01:00 ET

Terumo Corp Sees FY Net Y105.00B

Terumo Corp. also released the following forecasts: GROUP Year Ending Mar 2024 Operating Profit Y140.00 bln Pretax Profit N/A Net Profit Y

Dow JonesFeb 7 01:00 ET

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst

Needham initiated coverage on Inari Medical Inc (NASDAQ:NARI), noting it as a leader in the very large and underpenetrated market for venous thrombectomy. Inari Medical projects an annual patient popu

BenzingaJan 23 14:56 ET

Hikaru Samejima to Assume Position as President and CEO of Terumo Corp. in April 2024

Medical thermometer maker Terumo Corp. (TYO:4543) is implementing changes to its executive positions effective April 1, 2024, including the appointment of Hikaru Samejima, as its new president and CEO

MT NewswiresDec 14, 2023 06:08 ET

Terumo Reports 1H Results

Seeking AlphaNov 15, 2023 11:12 ET

Terumo GAAP EPS of ¥30.27, Revenue of ¥215.25B

Seeking AlphaAug 9, 2023 10:16 ET

Terumo Corp 1Q Net Y22.55B Vs Net Y22.40B

Terumo Corp. (4543.TO) Japan 1st Quarter Ended June 30 GROUP 2023 2022 Revenue Y215.25 bln Y197.34 bln Operating Profit Y29.64 bln Y30

Dow JonesAug 9, 2023 02:00 ET

Terumo GAAP EPS of ¥118.95, Revenue of ¥820.21B

Seeking AlphaMay 15, 2023 09:33 ET

Terumo Corp Sees FY Net Y101.00B

Terumo Corp. also released the following forecasts: GROUP Year Ending Mar 2024 Revenue Y854.00 bln Operating Profit Y132.50 bln Pretax Profit

Dow JonesMay 15, 2023 02:01 ET

Terumo Corp FY Net Y89.33B Vs Net Y88.81B

Terumo Corp. (4543.TO) Japan Year Ended March 31 GROUP 2023 2022 Revenue Y820.21 bln Y703.30 bln Operating Profit Y117.33 bln Y115

Dow JonesMay 15, 2023 02:01 ET

Terumo GAAP EPS of ¥93.21, Revenue of ¥617.99B

Seeking AlphaFeb 9, 2023 12:50 ET

Terumo Corp Sees FY Net Y91.50B

Terumo Corp. also released the following forecasts: GROUP Year Ending Mar 2023 Operating Profit Y122.00 bln Pretax Profit N/A Net Profit

Dow JonesFeb 9, 2023 01:06 ET

Terumo Reports Q2 Results

Seeking AlphaNov 14, 2022 13:43 ET

Terumo Corp 1H Net Y40.32B Vs Net Y49.99B

Terumo Corp. (4543.TO) Japan 1st Half Ended September 30 GROUP 2022 2021 Revenue Y403.32 bln Y344.64 bln Operating Profit Y55.98 bln Y

Dow JonesNov 10, 2022 01:04 ET

Terumo GAAP EPS of ¥29.61, revenue of ¥197.34B beats by ¥195.98B

Terumo press release (OTCPK:TRUMF): Q1 GAAP EPS of ¥29.61. Revenue of ¥197.34B (+14.9% Y/Y) beats by ¥195.98B.

Seeking AlphaAug 9, 2022 08:13 ET